Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Cash

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Neuroimmunology|May 1, 1993
The origin of the autoimmune disease-resistant LER rat: an outcross between the buffalo and autoimmune disease-prone Lewis inbred rat strainsE A Goldmuntz, R L Wilder, Y Goldfarb, et al.
Lupus|September 4, 2001
Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patientsP A McNeeley, G M Iverson, R A Furie, et al.
Arthritis and Rheumatism|August 1, 1995
Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup studyC D Radis, L E Kahl, G L Baker, et al.
Arthritis and Rheumatism|November 1, 1994
Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgiaL J Crofford, S R Pillemer, K T Kalogeras, et al.
The Journal of Rheumatology|March 15, 2001
Treatment of systemic lupus erythematosus with LJP 394R A Furie, J M Cash, M E Cronin, et al.
Arthritis and Rheumatism|November 12, 1998
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptidesL W Moreland, E E Morgan, T C Adamson, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Neuroimmunology|May 1, 1993
The origin of the autoimmune disease-resistant LER rat: an outcross between the buffalo and autoimmune disease-prone Lewis inbred rat strainsE A Goldmuntz, R L Wilder, Y Goldfarb, et al.
Lupus|September 4, 2001
Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patientsP A McNeeley, G M Iverson, R A Furie, et al.
Arthritis and Rheumatism|August 1, 1995
Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup studyC D Radis, L E Kahl, G L Baker, et al.
Arthritis and Rheumatism|November 1, 1994
Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgiaL J Crofford, S R Pillemer, K T Kalogeras, et al.
The Journal of Rheumatology|March 15, 2001
Treatment of systemic lupus erythematosus with LJP 394R A Furie, J M Cash, M E Cronin, et al.
Arthritis and Rheumatism|November 12, 1998
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptidesL W Moreland, E E Morgan, T C Adamson, et al.
Pageof 4